Insider Trading Insights: Penny Stocks Investors Should Watch Insider Trading Insights: Penny Stocks Investors Should Watch

Written By Michael Gary Scott



The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.


Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Insider Trading at Great Elm Group

  • The Trade: Great Elm Group, Inc. GEG 10% owner Imperial Capital Group Holdings II, LLC acquired a total of 124,090 shares at an average price of $1.96. The purchase amounted to approximately $238,539.
  • What’s Happening: On Feb. 13, Great Elm Group posted a loss for the second quarter.
  • What Great Elm Group Does: Great Elm Group Inc operates as a holding company, focusing on growing a scalable and diversified portfolio of long-duration, permanent capital vehicles.

Insider Trading at Earth Science Tech

  • The Trade: Earth Science Tech, Inc. ETST CEO Giorgio R. Saumat acquired a total of 15,000 shares at an average price of $0.08. The acquisition cost around $1,199.
  • What’s Happening: On Jan. 29, Earth Science Tech announced a $5 million common stock repurchase program.
  • What Earth Science Tech Does: Earth Science Tech Inc is a diversified holding company with a current focus on emerging prospects in the health and wellness industry.

Insider Trading at Emmaus Life Sciences

  • The Trade: Emmaus Life Sciences, Inc. EMMA Co-President and COO Willis C Lee acquired a total of 115,200 shares at an average price of $0.13. The insider spent around $14,694 to buy those shares.
  • What’s Happening: On Feb. 2, Emmaus Life Sciences received marketing authorization for Puerto Rico.
  • What Emmaus Life Sciences Does: Emmaus Life Sciences Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases.
See also  The Bright Future of Planet 13: A $225M Gamble on Florida's Legal Weed Market

Don’t forget to check out our premarket coverage here